At A Glance:

It’s no surprise that doctors are enthusiastic about the new CGRP class of migraine prevention drugs currently under development. More than 36 million Americans suffer from migraine attacks; of these, about 4 million have chronic migraine.

Download PDF


Enrollment time saved: 7 months
Randomized patients delivered: 56%
See the results